机器人辅助微创食管切除术的实施与效果:基于IDEAL框架的系统综述
该系统综述依据IDEAL框架评估机器人辅助微创食管切除术(RAMIO)的发展阶段,检索截至2025年6月1日,纳入104项研究共133 107例患者。多数研究为IDEAL 2B期,仅4项RCT(3期)和14项长期随访研究(4期),无研究明确引用IDEAL框架。RCT显示RAMIO在减少并发症和加速康复方面有优势,但长期结局不确定且证据质量有限。
要点
- RAMIO研究多数处于IDEAL 2B期,RCT仅4项,长期随访研究14项。
- RCT提示RAMIO可减少并发症并加速康复,但长期获益不明确。
- 现有研究未明确遵循IDEAL框架,长期结局研究异质性大且存在偏倚风险。
核心结论
- RAMIO可能提供围术期获益,但高质量证据有限,长期获益不明确。
- RAMIO研究发展大体符合IDEAL阶段,但缺乏对框架的明确遵循。
研究设计与样本
- 系统综述依据IDEAL框架,检索PubMed、Embase、Web of Science和Cochrane Library截至2025年6月1日。
- 纳入104项比较RAMIO与开放或微创食管切除术的研究,共133 107例患者,发表于2002至2025年。
- 两位评价者独立筛选和提取数据,按IDEAL阶段分类,叙事性总结结局,RCT用RoB-2、长期研究用ROBINS-I评估偏倚风险。
- 方案注册于PROSPERO(CRD42022352208)。
主要发现
- 104项研究中,86项为IDEAL 2B期,4项为3期(RCT),14项为4期(长期随访研究)。
- 部分4期研究在3期评估之前进行,且无研究明确引用IDEAL框架。
- RCT显示RAMIO减少并发症并加速康复,但长期结局不确定。
- 长期结局研究设计各异,常存在偏倚风险。
临床怎么用
- 临床决策应认识到RAMIO的围术期优势基于有限RCT证据,长期获益尚不明确。
- 未来试验应采用IDEAL框架指导的结构化设计和标准化报告。
局限性
- 高质量证据有限,RCT数量少。
- 长期结局研究异质性大且偏倚风险高。
- 研究未明确遵循IDEAL框架,可能影响证据分级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Robot-assisted minimally invasive oesophagectomy (RAMIO) is increasingly used for oesophageal cancer surgery, yet its adoption may have outpaced structured evaluation. This systematic review assessed RAMIO's development through the IDEAL framework and synthesized evidence from RCTs and long-term studies. METHODS: A systematic search was conducted in PubMed, Embase, Web of Science, and the Cochrane Library on 1 June 2025 for studies comparing RAMIO with open oesophagectomy or minimally invasive oesophagectomy. Non-comparative, non-English, protocol, and review articles were excluded. Two reviewers independently screened and extracted data, classifying studies according to IDEAL stages. Outcomes were presented in a narrative overview. Risk of bias was assessed using RoB-2 for RCTs and ROBINS-I for long-term studies. The protocol was registered in PROSPERO (CRD42022352208). RESULTS: A total of 104 studies involving 133 107 patients published between 2002 and 2025 were included. Of these, 86 were IDEAL stage 2B, four stage 3 (RCTs), and 14 stage 4 (long-term follow up studies). Generally, RAMIO research followed the IDEAL pathway, although several stage 4 studies preceded stage 3 evaluations. None explicitly referenced the IDEAL framework. RCTs demonstrated some benefits of RAMIO, including fewer complications and faster recovery, whereas long-term outcomes remain uncertain. Studies on long-term outcomes varied in design and were often at risk of bias. CONCLUSION: RAMIO may offer perioperative benefits, but high-quality evidence is limited. Few RCTs exist, and long-term benefits are unclear. Although RAMIO development aligns broadly with IDEAL stages, explicit framework adherence is lacking. Future trials should adopt structured IDEAL-guided designs and standardised reporting.
引用
- Kuiper GM, Triemstra L, den Boer RB, et al. Implementation and effectiveness of robot-assisted minimally invasive oesophagectomy (RAMIO): a systematic review using the IDEAL framework. Br J Surg. 2025. PMID: 41363809. doi:10.1093/bjs/znaf265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。